Back to User profile » Dr Jian-Hong Zhong

Papers published by Dr Jian-Hong Zhong:

Commentary

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

Zhong J, Luo C, Zhang C, Li L

Journal of Hepatocellular Carcinoma 2017, 4:11-13

Published Date: 30 December 2016

Letter

Are another 5 years of adjuvant aromatase inhibitor therapy needed?

Mo QG, Li DQ, Zhong JH, Wei CY

Breast Cancer: Targets and Therapy 2016, 8:207-209

Published Date: 14 November 2016

Original Research

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection

Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ

OncoTargets and Therapy 2016, 9:6897-6907

Published Date: 10 November 2016

Original Research

Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis

Zhu SL, Zhong JH, Gong WF, Li H, Li LQ

OncoTargets and Therapy 2016, 9:2111-2119

Published Date: 15 April 2016

Letter

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma

Zhong JH, Xiang BD, Li LQ

Drug Design, Development and Therapy 2015, 9:5623-5624

Published Date: 13 October 2015